You searched for "legislation"
ChatGPT cannot pass FRCOphth examinations: implications for ophthalmology and large language model artificial intelligence
Large language models are generating a lot of hype for artificial intelligence, but can they assist patients and practitioners in ophthalmology? Introduction Deep learning (DL) has emerged in ophthalmology as an exciting form of artificial intelligence (AI) most commonly applied...RCOphth Annual Congress - Day 2
Follow all the key updates from the RCOphth Annual Congress 2022, live.Practice tips: Directions in cataract surgery services and preventing postcataract endophthalmitis
Future directions in the delivery of high quality cataract surgery services and approved intracameral prophylactic approaches to lowering the risk of postcataract infective endophthalmitis were debated by consultant ophthalmic surgeons in a recent London seminar, held at the Royal Society...From the Editors: Back in the habit!
Recently I spoke at an ophthalmic conference in London. It was amazing to be back amongst friends and colleagues in person again, to learn and share with one another. I also took the opportunity to stay on for a few...Novel retinal pigment metric tackles bias in AI models
Researchers have developed an innovative metric for objectively classifying pigmentation in a retinal image, rather than using subjective social constructs like ethnicity or other demographic variables, as is currently the case when building health datasets. Called the Retinal Pigment Score...Topcon Healthcare Launches IDHea™ to Fuel AI and Digital Health Innovation from the Eye
Topcon Healthcare, Inc., a global leader in robotic diagnostics and digital health solutions, announced the launch of the Institute of Digital Health (IDHea™), an ocular data-as-a-service platform designed to accelerate AI research and digital health innovation. IDHea provides fast and...Major grant secured to transform immune cell imaging research
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...
Intravitreal afibercept and ranibizumab for PCV
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
What effects do repeated Ozurdex implants have in paediatric uveitis?
The aim of this retrospective study was to assess the anatomical and functional results, as well as complications of repeated Ozurdex intravitreal implants in a paediatric (non-infectious) uveitis cohort. Twenty-two eyes (16 patients) received 35 Ozurdex implants over a six...
Post hoc analysis of the CANTREAT randomised trial
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
